Mezoo was established in 2007 in Wonju, Korea. We originally
started as an R&D firm that developed wearable Holter, invasive
blood glucose algorithm, 3/5/12 lead ECGs, IoMT Platform, and
the HiCardi system.
The area of biomedical engineering that we focus on is the
development and manufacturing of wearable SmartPatches,
mobile, and web-based software.
For that, we are committed to developing new Mobile Cardiac
Technologies, such as the world’s smallest biosensors, reliable
and precise bio-signal measurements. We believe that our
innovative remote/real-time/cableless HiCardi system supports
medical professionals monitoring and managing patients who
suffering from cardiac disorders.